Given the finding that CXCR4 is upregulated on CD4+ and CD8+ T cells during sepsis, we hypothesized that blocking these signals using a CXCR4 blocking agent could improve survival and immune dysregulation in a murine model of polymicrobial sepsis. The gene discussed is CD8A; the disease is Sepsis.